{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:23:06Z","timestamp":1787062986433,"version":"build-2736575974"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12325-025-03312-6","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T09:19:50Z","timestamp":1753262390000},"page":"4255-4269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Obstructive Sleep Apnea: An Evolving Therapeutic Landscape with an Emerging Role for Incretin-Based Therapies"],"prefix":"10.1007","volume":"42","author":[{"given":"Bolong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Gaynor-Sodeifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Kundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"3312_CR1","doi-asserted-by":"publisher","unstructured":"Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association\/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080\u2013111. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.189375.","DOI":"10.1161\/CIRCULATIONAHA.107.189375"},{"key":"3312_CR2","doi-asserted-by":"publisher","unstructured":"Malhotra A, Ayappa I, Ayas N, et al. Metrics of sleep apnea severity: beyond the apnea-hypopnea index. Sleep. 2021;44(7). https:\/\/doi.org\/10.1093\/sleep\/zsab030.","DOI":"10.1093\/sleep\/zsab030"},{"issue":"4","key":"3312_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S2213-2600(15)00043-0","volume":"3","author":"R Heinzer","year":"2015","unstructured":"Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3(4):310\u20138. https:\/\/doi.org\/10.1016\/S2213-2600(15)00043-0.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"3312_CR4","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/aje\/kws342","volume":"177","author":"PE Peppard","year":"2013","unstructured":"Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006\u201314. https:\/\/doi.org\/10.1093\/aje\/kws342.","journal-title":"Am J Epidemiol"},{"issue":"9918","key":"3312_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0140-6736(13)60734-5","volume":"383","author":"AS Jordan","year":"2014","unstructured":"Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383(9918):736\u201347. https:\/\/doi.org\/10.1016\/S0140-6736(13)60734-5.","journal-title":"Lancet"},{"issue":"3","key":"3312_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.chest.2017.06.011","volume":"153","author":"JC Carberry","year":"2018","unstructured":"Carberry JC, Amatoury J, Eckert DJ. Personalized management approach for OSA. Chest. 2018;153(3):744\u201355. https:\/\/doi.org\/10.1016\/j.chest.2017.06.011.","journal-title":"Chest"},{"key":"3312_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.smrv.2016.01.007","volume":"31","author":"BC Neelapu","year":"2017","unstructured":"Neelapu BC, Kharbanda OP, Sardana HK, et al. Craniofacial and upper airway morphology in adult obstructive sleep apnea patients: a systematic review and meta-analysis of cephalometric studies. Sleep Med Rev. 2017;31:79\u201390. https:\/\/doi.org\/10.1016\/j.smrv.2016.01.007.","journal-title":"Sleep Med Rev"},{"issue":"Pt 3","key":"3312_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1113\/jphysiol.2007.132332","volume":"581","author":"DJ Eckert","year":"2007","unstructured":"Eckert DJ, McEvoy RD, George KE, Thomson KJ, Catcheside PG. Genioglossus reflex inhibition to upper-airway negative-pressure stimuli during wakefulness and sleep in healthy males. J Physiol. 2007;581(Pt 3):1193\u2013205. https:\/\/doi.org\/10.1113\/jphysiol.2007.132332.","journal-title":"J Physiol"},{"key":"3312_CR9","doi-asserted-by":"publisher","unstructured":"Eckert DJ, Younes MK. Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment. J Appl Physiol (1985). 2014;116(3):302\u201313. https:\/\/doi.org\/10.1152\/japplphysiol.00649.2013.","DOI":"10.1152\/japplphysiol.00649.2013"},{"issue":"12","key":"3312_CR10","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1164\/rccm.202306-1036OC","volume":"208","author":"PK Schweitzer","year":"2023","unstructured":"Schweitzer PK, Taranto-Montemurro L, Ojile JM, et al. The combination of aroxybutynin and atomoxetine in the treatment of obstructive sleep apnea (MARIPOSA): a randomized controlled trial. Am J Respir Crit Care Med. 2023;208(12):1316\u201327. https:\/\/doi.org\/10.1164\/rccm.202306-1036OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3312_CR11","doi-asserted-by":"publisher","first-page":"811","DOI":"10.5665\/sleep.3596","volume":"37","author":"DJ Eckert","year":"2014","unstructured":"Eckert DJ, Malhotra A, Wellman A, White DP. Trazodone increases the respiratory arousal threshold in patients with obstructive sleep apnea and a low arousal threshold. Sleep. 2014;37(4):811\u20139. https:\/\/doi.org\/10.5665\/sleep.3596.","journal-title":"Sleep"},{"key":"3312_CR12","doi-asserted-by":"publisher","unstructured":"Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med. 2013;188(8):996\u20131004. https:\/\/doi.org\/10.1164\/rccm.201303-0448OC.","DOI":"10.1164\/rccm.201303-0448OC"},{"issue":"2","key":"3312_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5665\/sleep.2390","volume":"36","author":"BA Edwards","year":"2013","unstructured":"Edwards BA, Connolly JG, Campana LM, et al. Acetazolamide attenuates the ventilatory response to arousal in patients with obstructive sleep apnea. Sleep. 2013;36(2):281\u20135. https:\/\/doi.org\/10.5665\/sleep.2390.","journal-title":"Sleep"},{"issue":"11","key":"3312_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1164\/rccm.201404-0718OC","volume":"190","author":"BA Edwards","year":"2014","unstructured":"Edwards BA, Eckert DJ, McSharry DG, et al. Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2014;190(11):1293\u2013300. https:\/\/doi.org\/10.1164\/rccm.201404-0718OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"3312_CR15","doi-asserted-by":"publisher","unstructured":"Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol (1985). 2005;99(4):1592\u20139. https:\/\/doi.org\/10.1152\/japplphysiol.00587.2005.","DOI":"10.1152\/japplphysiol.00587.2005"},{"issue":"3","key":"3312_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2206038.","journal-title":"N Engl J Med"},{"issue":"8","key":"3312_CR17","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/resp.13144","volume":"22","author":"G Lorenzi-Filho","year":"2017","unstructured":"Lorenzi-Filho G, Almeida FR, Strollo PJ. Treating OSA: current and emerging therapies beyond CPAP. Respirology. 2017;22(8):1500\u20137. https:\/\/doi.org\/10.1111\/resp.13144.","journal-title":"Respirology"},{"issue":"1","key":"3312_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5664\/jcsm.10832","volume":"20","author":"SP Patil","year":"2024","unstructured":"Patil SP, Billings ME, Bourjeily G, et al. Long-term health outcomes for patients with obstructive sleep apnea: placing the agency for healthcare research and quality report in context-a multisociety commentary. J Clin Sleep Med. 2024;20(1):135\u201349. https:\/\/doi.org\/10.5664\/jcsm.10832.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"3312_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5664\/jcsm.7638","volume":"15","author":"SP Patil","year":"2019","unstructured":"Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: an American academy of sleep medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2019;15(2):301\u201334. https:\/\/doi.org\/10.5664\/jcsm.7638.","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"3312_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/sleep\/29.3.375","volume":"29","author":"CA Kushida","year":"2006","unstructured":"Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006;29(3):375\u201380. https:\/\/doi.org\/10.1093\/sleep\/29.3.375.","journal-title":"Sleep"},{"issue":"10","key":"3312_CR21","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/sleep\/33.10.1373","volume":"33","author":"S Tregear","year":"2010","unstructured":"Tregear S, Reston J, Schoelles K, Phillips B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis. Sleep. 2010;33(10):1373\u201380. https:\/\/doi.org\/10.1093\/sleep\/33.10.1373.","journal-title":"Sleep"},{"issue":"13","key":"3312_CR22","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.jacc.2024.07.024","volume":"84","author":"S Javaheri","year":"2024","unstructured":"Javaheri S, Javaheri S, Gozal D, et al. Treatment of OSA and its impact on cardiovascular disease, part 2: JACC state-of-the-art review. J Am Coll Cardiol. 2024;84(13):1224\u201340. https:\/\/doi.org\/10.1016\/j.jacc.2024.07.024.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"3312_CR23","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1001\/jama.2012.4366","volume":"307","author":"F Barbe","year":"2012","unstructured":"Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307(20):2161\u20138. https:\/\/doi.org\/10.1001\/jama.2012.4366.","journal-title":"JAMA"},{"issue":"10","key":"3312_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1606599","volume":"375","author":"RD McEvoy","year":"2016","unstructured":"McEvoy RD, Antic NA, Heeley E, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375(10):919\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1606599.","journal-title":"N Engl J Med"},{"key":"3312_CR25","doi-asserted-by":"publisher","unstructured":"Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunstrom E. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial. Am J Respir Crit Care Med. 2016;194(5):613\u201320. https:\/\/doi.org\/10.1164\/rccm.201601-0088OC.","DOI":"10.1164\/rccm.201601-0088OC"},{"issue":"4","key":"3312_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S2213-2600(19)30271-1","volume":"8","author":"M Sanchez-de-la-Torre","year":"2020","unstructured":"Sanchez-de-la-Torre M, Sanchez-de-la-Torre A, Bertran S, et al. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med. 2020;8(4):359\u201367. https:\/\/doi.org\/10.1016\/S2213-2600(19)30271-1.","journal-title":"Lancet Respir Med"},{"issue":"7","key":"3312_CR27","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1513\/AnnalsATS.202309-799OC","volume":"21","author":"O Cohen","year":"2024","unstructured":"Cohen O, S\u00e1nchez-de-la-Torre M, Al-Taie Z, et al. Heterogeneous effects of continuous positive airway pressure in non-sleepy obstructive sleep apnea on cardiovascular disease outcomes: post hoc machine learning analysis of the ISAACC trial (ECSACT study). Ann Am Thorac Soc. 2024;21(7):1074\u201384. https:\/\/doi.org\/10.1513\/AnnalsATS.202309-799OC.","journal-title":"Ann Am Thorac Soc"},{"key":"3312_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.sleep.2022.05.007","volume":"96","author":"DJ Gottlieb","year":"2022","unstructured":"Gottlieb DJ, Lederer DJ, Kim JS, et al. Effect of positive airway pressure therapy of obstructive sleep apnea on circulating angiopoietin-2. Sleep Med. 2022;96:119\u201321. https:\/\/doi.org\/10.1016\/j.sleep.2022.05.007.","journal-title":"Sleep Med"},{"key":"3312_CR29","doi-asserted-by":"publisher","unstructured":"Cohen O, Kundel V, Barb\u00e9 F, et al. The great controversy of obstructive sleep apnea treatment for cardiovascular risk benefit: advancing the science through expert consensus. An official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2024. https:\/\/doi.org\/10.1513\/AnnalsATS.202409-981ST.","DOI":"10.1513\/AnnalsATS.202409-981ST"},{"issue":"1","key":"3312_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40463-016-0156-0","volume":"45","author":"BW Rotenberg","year":"2016","unstructured":"Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg. 2016;45(1):43. https:\/\/doi.org\/10.1186\/s40463-016-0156-0.","journal-title":"J Otolaryngol Head Neck Surg."},{"issue":"2","key":"3312_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00408-018-00193-1","volume":"197","author":"M Mehrtash","year":"2019","unstructured":"Mehrtash M, Bakker JP, Ayas N. Predictors of continuous positive airway pressure adherence in patients with obstructive sleep apnea. Lung. 2019;197(2):115\u201321. https:\/\/doi.org\/10.1007\/s00408-018-00193-1.","journal-title":"Lung"},{"issue":"02","key":"3312_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5664\/jcsm.3460","volume":"10","author":"K Sutherland","year":"2014","unstructured":"Sutherland K, Vanderveken OM, Tsuda H, et al. Oral appliance treatment for obstructive sleep apnea: an update. J Clin Sleep Med. 2014;10(02):215\u201327. https:\/\/doi.org\/10.5664\/jcsm.3460.","journal-title":"J Clin Sleep Med"},{"key":"3312_CR33","doi-asserted-by":"publisher","unstructured":"Bamagoos AA, Cistulli PA, Sutherland K, et al. Dose-dependent effects of mandibular advancement on upper airway collapsibility and muscle function in obstructive sleep apnea. Sleep. 2019;42(6). https:\/\/doi.org\/10.1093\/sleep\/zsz049.","DOI":"10.1093\/sleep\/zsz049"},{"issue":"11","key":"3312_CR34","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1164\/rccm.201601-0099OC","volume":"194","author":"BA Edwards","year":"2016","unstructured":"Edwards BA, Andara C, Landry S, et al. Upper-airway collapsibility and loop gain predict the response to oral appliance therapy in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2016;194(11):1413\u201322. https:\/\/doi.org\/10.1164\/rccm.201601-0099OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3312_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1164\/rccm.200211-1275OC","volume":"168","author":"AT Ng","year":"2003","unstructured":"Ng AT, Gotsopoulos H, Qian J, Cistulli PA. Effect of oral appliance therapy on upper airway collapsibility in obstructive sleep Apnea. Am J Respir Crit Care Med. 2003;168(2):238\u201341. https:\/\/doi.org\/10.1164\/rccm.200211-1275OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3312_CR36","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1164\/rccm.201212-2223OC","volume":"187","author":"CL Phillips","year":"2013","unstructured":"Phillips CL, Grunstein RR, Darendeliler MA, et al. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea. Am J Respir Crit Care Med. 2013;187(8):879\u201387. https:\/\/doi.org\/10.1164\/rccm.201212-2223OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3312_CR37","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1378\/chest.128.4.2130","volume":"128","author":"MJ Mador","year":"2005","unstructured":"Mador MJ, Kufel TJ, Magalang UJ, Rajesh SK, Watwe V, Grant BJ. Prevalence of positional sleep apnea in patients undergoing polysomnography. Chest. 2005;128(4):2130\u20137. https:\/\/doi.org\/10.1378\/chest.128.4.2130.","journal-title":"Chest"},{"issue":"2","key":"3312_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11325-017-1561-y","volume":"22","author":"O Omobomi","year":"2018","unstructured":"Omobomi O, Quan SF. Positional therapy in the management of positional obstructive sleep apnea\u2014a review of the current literature. Sleep Breath. 2018;22(2):297\u2013304. https:\/\/doi.org\/10.1007\/s11325-017-1561-y.","journal-title":"Sleep Breath"},{"issue":"6","key":"3312_CR39","doi-asserted-by":"publisher","first-page":"813","DOI":"10.5664\/jcsm.6622","volume":"13","author":"MJL Ravesloot","year":"2017","unstructured":"Ravesloot MJL, White D, Heinzer R, Oksenberg A, Pepin JL. Efficacy of the new generation of devices for positional therapy for patients with positional obstructive sleep apnea: a systematic review of the literature and meta-analysis. J Clin Sleep Med. 2017;13(6):813\u201324. https:\/\/doi.org\/10.5664\/jcsm.6622.","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"3312_CR40","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s13311-012-0141-x","volume":"9","author":"B Carvalho","year":"2012","unstructured":"Carvalho B, Hsia J, Capasso R. Surgical therapy of obstructive sleep apnea: a review. Neurotherapeutics. 2012;9(4):710\u20136. https:\/\/doi.org\/10.1007\/s13311-012-0141-x.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"3312_CR41","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/0194599816661481","volume":"155","author":"JH Choi","year":"2016","unstructured":"Choi JH, Cho SH, Kim SN, Suh JD, Cho JH. Predicting outcomes after uvulopalatopharyngoplasty for adult obstructive sleep apnea: a meta-analysis. Otolaryngol Head Neck Surg. 2016;155(6):904\u201313. https:\/\/doi.org\/10.1177\/0194599816661481.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"3312_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jsmc.2016.04.003","volume":"11","author":"SG MacKay","year":"2016","unstructured":"MacKay SG, Chan L. Surgical approaches to obstructive sleep apnea. Sleep Med Clin. 2016;11(3):331\u201341. https:\/\/doi.org\/10.1016\/j.jsmc.2016.04.003.","journal-title":"Sleep Med Clin"},{"issue":"6","key":"3312_CR43","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1378\/chest.14-2078","volume":"147","author":"DF Smith","year":"2015","unstructured":"Smith DF, Cohen AP, Ishman SL. Surgical management of OSA in adults. Chest. 2015;147(6):1681\u201390. https:\/\/doi.org\/10.1378\/chest.14-2078.","journal-title":"Chest"},{"issue":"2","key":"3312_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1056\/NEJMoa1308659","volume":"370","author":"PJ Strollo Jr","year":"2014","unstructured":"Strollo PJ Jr, Soose RJ, Maurer JT, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014;370(2):139\u201349. https:\/\/doi.org\/10.1056\/NEJMoa1308659.","journal-title":"N Engl J Med"},{"issue":"10","key":"3312_CR45","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1007\/s00405-023-08062-1","volume":"280","author":"M Braun","year":"2023","unstructured":"Braun M, Stoerzel M, Wollny M, Schoebel C, Ulrich Sommer J, Heiser C. Patient-reported outcomes with hypoglossal nerve stimulation for treatment of obstructive sleep apnea: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2023;280(10):4627\u201339. https:\/\/doi.org\/10.1007\/s00405-023-08062-1.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3312_CR46","doi-asserted-by":"publisher","unstructured":"Eastwood PR, Barnes M, MacKay SG, et al. Bilateral hypoglossal nerve stimulation for treatment of adult obstructive sleep apnoea. Eur Respir J. 2020;55(1). https:\/\/doi.org\/10.1183\/13993003.01320-2019.","DOI":"10.1183\/13993003.01320-2019"},{"key":"3312_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106804","volume":"119","author":"O Jacobowitz","year":"2022","unstructured":"Jacobowitz O, Schwartz AR, Lovett EG, Ranuzzi G, Malhotra A. Design and rationale for the treating obstructive sleep apnea using targeted hypoglossal nerve stimulation (OSPREY) trial. Contemp Clin Trials. 2022;119: 106804. https:\/\/doi.org\/10.1016\/j.cct.2022.106804.","journal-title":"Contemp Clin Trials"},{"issue":"6","key":"3312_CR48","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jamaoto.2023.0231","volume":"149","author":"SM Jara","year":"2023","unstructured":"Jara SM, Jackson RS. Targeted hypoglossal nerve stimulation-an inspiring alternative for obstructive sleep apnea. JAMA Otolaryngol Head Neck Surg. 2023;149(6):520\u20131. https:\/\/doi.org\/10.1001\/jamaoto.2023.0231.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"3312_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2024.101947","volume":"76","author":"MM Serghani","year":"2024","unstructured":"Serghani MM, Heiser C, Schwartz AR, Amatoury J. Exploring hypoglossal nerve stimulation therapy for obstructive sleep apnea: a comprehensive review of clinical and physiological upper airway outcomes. Sleep Med Rev. 2024;76: 101947. https:\/\/doi.org\/10.1016\/j.smrv.2024.101947.","journal-title":"Sleep Med Rev"},{"issue":"3","key":"3312_CR50","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.chest.2020.10.010","volume":"159","author":"DT Kent","year":"2021","unstructured":"Kent DT, Zealear D, Schwartz AR. Ansa cervicalis stimulation: a new direction in neurostimulation for OSA. Chest. 2021;159(3):1212\u201321. https:\/\/doi.org\/10.1016\/j.chest.2020.10.010.","journal-title":"Chest"},{"key":"3312_CR51","doi-asserted-by":"publisher","unstructured":"Baptista PM, Martinez Ruiz de Apodaca P, Carrasco M, et al. Daytime neuromuscular electrical therapy of tongue muscles in improving snoring in individuals with primary snoring and mild obstructive sleep apnea. J Clin Med. 2021;10(9). https:\/\/doi.org\/10.3390\/jcm10091883.","DOI":"10.3390\/jcm10091883"},{"issue":"1","key":"3312_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1440-1843.2011.02093.x","volume":"17","author":"S Isono","year":"2012","unstructured":"Isono S. Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway. Respirology. 2012;17(1):32\u201342. https:\/\/doi.org\/10.1111\/j.1440-1843.2011.02093.x.","journal-title":"Respirology"},{"key":"3312_CR53","doi-asserted-by":"publisher","unstructured":"Wang SH, Keenan BT, Wiemken A, et al. Effect of weight loss on upper airway anatomy and the apnea-hypopnea index. The importance of tongue fat. Am J Respir Crit Care Med. 2020;201(6):718\u2013727. https:\/\/doi.org\/10.1164\/rccm.201903-0692OC.","DOI":"10.1164\/rccm.201903-0692OC"},{"key":"3312_CR54","doi-asserted-by":"publisher","unstructured":"Schwartz AR, Patil SP, Squier S, Schneider H, Kirkness JP, Smith PL. Obesity and upper airway control during sleep. J Appl Physiol (1985). 2010;108(2):430\u20135. https:\/\/doi.org\/10.1152\/japplphysiol.00919.2009.","DOI":"10.1152\/japplphysiol.00919.2009"},{"issue":"9","key":"3312_CR55","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despres JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715\u201325. https:\/\/doi.org\/10.1016\/S2213-8587(19)30084-1.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"3312_CR56","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.numecd.2020.01.013","volume":"30","author":"Z Bagyura","year":"2020","unstructured":"Bagyura Z, Kiss L, Lux A, et al. Association between coronary atherosclerosis and visceral adiposity index. Nutr Metab Cardiovasc Dis. 2020;30(5):796\u2013803. https:\/\/doi.org\/10.1016\/j.numecd.2020.01.013.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"3312_CR57","doi-asserted-by":"publisher","first-page":"821","DOI":"10.5551\/jat.47274","volume":"26","author":"E Randrianarisoa","year":"2019","unstructured":"Randrianarisoa E, Lehn-Stefan A, Hieronimus A, et al. Visceral adiposity index as an independent marker of subclinical atherosclerosis in individuals prone to diabetes mellitus. J Atheroscler Thromb. 2019;26(9):821\u201334. https:\/\/doi.org\/10.5551\/jat.47274.","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"3312_CR58","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.004043","volume":"9","author":"AL Figueroa","year":"2016","unstructured":"Figueroa AL, Takx RA, MacNabb MH, et al. Relationship between measures of adiposity, arterial inflammation, and subsequent cardiovascular events. Circ Cardiovasc Imaging. 2016;9(4): e004043. https:\/\/doi.org\/10.1161\/CIRCIMAGING.115.004043.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"3312_CR59","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1210\/jcem.85.3.6484","volume":"85","author":"AN Vgontzas","year":"2000","unstructured":"Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85(3):1151\u20138. https:\/\/doi.org\/10.1210\/jcem.85.3.6484.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"3312_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185403","volume":"12","author":"TW Elffers","year":"2017","unstructured":"Elffers TW, de Mutsert R, Lamb HJ, et al. Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women. PLoS One. 2017;12(9): e0185403. https:\/\/doi.org\/10.1371\/journal.pone.0185403.","journal-title":"PLoS One"},{"issue":"1","key":"3312_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","volume":"116","author":"CS Fox","year":"2007","unstructured":"Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation. 2007;116(1):39\u201348. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.675355.","journal-title":"Circulation"},{"key":"3312_CR62","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.2147\/NSS.S327341","volume":"13","author":"V Kundel","year":"2021","unstructured":"Kundel V, Lehane D, Ramachandran S, et al. Measuring visceral adipose tissue metabolic activity in sleep apnea utilizing hybrid (18)F-FDG PET\/MRI: a pilot study. Nat Sci Sleep. 2021;13:1943\u201353. https:\/\/doi.org\/10.2147\/NSS.S327341.","journal-title":"Nat Sci Sleep"},{"issue":"3","key":"3312_CR63","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1183\/09031936.00183411","volume":"41","author":"I Kritikou","year":"2013","unstructured":"Kritikou I, Basta M, Tappouni R, et al. Sleep apnoea and visceral adiposity in middle-aged male and female subjects. Eur Respir J. 2013;41(3):601\u20139. https:\/\/doi.org\/10.1183\/09031936.00183411.","journal-title":"Eur Respir J"},{"issue":"8","key":"3312_CR64","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1365-2362.2008.01984.x","volume":"38","author":"AN Vgontzas","year":"2008","unstructured":"Vgontzas AN, Zoumakis E, Bixler EO, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest. 2008;38(8):585\u201395. https:\/\/doi.org\/10.1111\/j.1365-2362.2008.01984.x.","journal-title":"Eur J Clin Invest"},{"key":"3312_CR65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.sleep.2024.06.014","volume":"121","author":"A Malhotra","year":"2024","unstructured":"Malhotra A, Heilmann CR, Banerjee KK, Dunn JP, Bunck MC, Bednarik J. Weight reduction and the impact on apnea-hypopnea index: a systematic meta-analysis. Sleep Med. 2024;121:26\u201331. https:\/\/doi.org\/10.1016\/j.sleep.2024.06.014.","journal-title":"Sleep Med"},{"issue":"23","key":"3312_CR66","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1001\/jama.284.23.3015","volume":"284","author":"PE Peppard","year":"2000","unstructured":"Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284(23):3015\u201321.","journal-title":"JAMA"},{"issue":"11","key":"3312_CR67","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","volume":"4","author":"ARG Look","year":"2016","unstructured":"Look ARG, Gregg EW, Jakicic JM, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4(11):913\u201321. https:\/\/doi.org\/10.1016\/S2213-8587(16)30162-0.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3312_CR68","doi-asserted-by":"publisher","unstructured":"Hudgel DW, Patel SR, Ahasic AM, et al. The role of weight management in the treatment of adult obstructive sleep apnea. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2018;198(6):e70\u2013e87. https:\/\/doi.org\/10.1164\/rccm.201807-1326ST.","DOI":"10.1164\/rccm.201807-1326ST"},{"issue":"2","key":"3312_CR69","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.chest.2019.09.002","volume":"157","author":"A Zinchuk","year":"2020","unstructured":"Zinchuk A, Yaggi HK. Phenotypic subtypes of OSA: a challenge and opportunity for precision medicine. Chest. 2020;157(2):403\u201320. https:\/\/doi.org\/10.1016\/j.chest.2019.09.002.","journal-title":"Chest"},{"issue":"9","key":"3312_CR70","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1164\/rccm.201707-1435OC","volume":"197","author":"SA Sands","year":"2018","unstructured":"Sands SA, Edwards BA, Terrill PI, et al. Phenotyping pharyngeal pathophysiology using polysomnography in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2018;197(9):1187\u201397. https:\/\/doi.org\/10.1164\/rccm.201707-1435OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3312_CR71","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1183\/09031936.00062914","volume":"45","author":"PI Terrill","year":"2015","unstructured":"Terrill PI, Edwards BA, Nemati S, et al. Quantifying the ventilatory control contribution to sleep apnoea using polysomnography. Eur Respir J. 2015;45(2):408\u201318. https:\/\/doi.org\/10.1183\/09031936.00062914.","journal-title":"Eur Respir J"},{"key":"3312_CR72","doi-asserted-by":"publisher","unstructured":"Sands SA, Terrill PI, Edwards BA, et al. Quantifying the arousal threshold using polysomnography in obstructive sleep apnea. Sleep. 2018;41(1). https:\/\/doi.org\/10.1093\/sleep\/zsx183.","DOI":"10.1093\/sleep\/zsx183"},{"key":"3312_CR73","doi-asserted-by":"publisher","unstructured":"Sands SA, Edwards BA, Terrill PI, et al. Identifying obstructive sleep apnoea patients responsive to supplemental oxygen therapy. Eur Respir J. 2018;52(3). https:\/\/doi.org\/10.1183\/13993003.00674-2018.","DOI":"10.1183\/13993003.00674-2018"},{"issue":"5","key":"3312_CR74","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.chest.2022.12.029","volume":"163","author":"C Strassberger","year":"2023","unstructured":"Strassberger C, Hedner J, Sands SA, et al. Night-to-night variability of polysomnography-derived physiologic endotypic traits in patients with moderate to severe OSA. Chest. 2023;163(5):1266\u201378. https:\/\/doi.org\/10.1016\/j.chest.2022.12.029.","journal-title":"Chest"},{"key":"3312_CR75","doi-asserted-by":"publisher","unstructured":"Tolbert TM, Schoenholz RL, Parekh A, et al. Night-to-night reliability and agreement of obstructive sleep apnea pathophysiologic mechanisms estimated with phenotyping using polysomnography in cognitively normal elderly participants. Sleep. 2023;46(8). https:\/\/doi.org\/10.1093\/sleep\/zsad058.","DOI":"10.1093\/sleep\/zsad058"},{"key":"3312_CR76","unstructured":"Apnimed announces positive results in clinical trial of sleep apnea medication. Industry Release. American Academy of Sleep Medicine. 2025.https:\/\/aasm.org\/apnimed-announces-positive-results-in-clinical-trial-of-sleep-apnea-medication\/. Accessed 6\/26\/2025."},{"key":"3312_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2025.03.013","author":"L Messineo","year":"2025","unstructured":"Messineo L, Preuss M, Azarbarzin A, et al. The combination of pimavanserin and atomoxetine reduces obstructive sleep apnea severity: a randomized crossover trial. Chest. 2025. https:\/\/doi.org\/10.1016\/j.chest.2025.03.013.","journal-title":"Chest."},{"issue":"7","key":"3312_CR78","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1164\/rccm.201511-2172OC","volume":"194","author":"L Taranto-Montemurro","year":"2016","unstructured":"Taranto-Montemurro L, Edwards BA, Sands SA, et al. Desipramine increases genioglossus activity and reduces upper airway collapsibility during non-REM sleep in healthy subjects. Am J Respir Crit Care Med. 2016;194(7):878\u201385. https:\/\/doi.org\/10.1164\/rccm.201511-2172OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3312_CR79","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1183\/13993003.00823-2016","volume":"48","author":"L Taranto-Montemurro","year":"2016","unstructured":"Taranto-Montemurro L, Sands SA, Edwards BA, et al. Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation. Eur Respir J. 2016;48(5):1340\u201350. https:\/\/doi.org\/10.1183\/13993003.00823-2016.","journal-title":"Eur Respir J"},{"issue":"5","key":"3312_CR80","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1113\/jphysiol.2011.223925","volume":"590","author":"BA Edwards","year":"2012","unstructured":"Edwards BA, Sands SA, Eckert DJ, et al. Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea. J Physiol. 2012;590(5):1199\u2013211. https:\/\/doi.org\/10.1113\/jphysiol.2011.223925.","journal-title":"J Physiol"},{"issue":"12","key":"3312_CR81","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1164\/rccm.202109-2043OC","volume":"205","author":"J Hedner","year":"2022","unstructured":"Hedner J, Stenl\u00f6f K, Zou D, et al. A randomized controlled clinical trial exploring safety and tolerability of sulthiame in sleep apnea. Am J Respir Crit Care Med. 2022;205(12):1461\u20139. https:\/\/doi.org\/10.1164\/rccm.202109-2043OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3312_CR82","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.resp.2008.05.019","volume":"162","author":"A Wellman","year":"2008","unstructured":"Wellman A, Malhotra A, Jordan AS, Stevenson KE, Gautam S, White DP. Effect of oxygen in obstructive sleep apnea: role of loop gain. Respir Physiol Neurobiol. 2008;162(2):144\u201351. https:\/\/doi.org\/10.1016\/j.resp.2008.05.019.","journal-title":"Respir Physiol Neurobiol"},{"issue":"24","key":"3312_CR83","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1056\/NEJMoa1306766","volume":"370","author":"DJ Gottlieb","year":"2014","unstructured":"Gottlieb DJ, Punjabi NM, Mehra R, et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med. 2014;370(24):2276\u201385. https:\/\/doi.org\/10.1056\/NEJMoa1306766.","journal-title":"N Engl J Med"},{"issue":"2 Pt 1","key":"3312_CR84","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1164\/ajrccm.151.2.7842205","volume":"151","author":"RB Berry","year":"1995","unstructured":"Berry RB, Kouchi K, Bower J, Prosise G, Light RW. Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 1995;151(2 Pt 1):450\u20134. https:\/\/doi.org\/10.1164\/ajrccm.151.2.7842205.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3312_CR85","doi-asserted-by":"publisher","first-page":"757","DOI":"10.5665\/sleep.5622","volume":"39","author":"SG Carter","year":"2016","unstructured":"Carter SG, Berger MS, Carberry JC, et al. Zopiclone increases the arousal threshold without impairing genioglossus activity in obstructive sleep apnea. Sleep. 2016;39(4):757\u201366. https:\/\/doi.org\/10.5665\/sleep.5622.","journal-title":"Sleep"},{"issue":"12","key":"3312_CR86","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1042\/CS20100588","volume":"120","author":"DJ Eckert","year":"2011","unstructured":"Eckert DJ, Owens RL, Kehlmann GB, et al. Eszopiclone increases the respiratory arousal threshold and lowers the apnoea\/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Clin Sci (Lond). 2011;120(12):505\u201314. https:\/\/doi.org\/10.1042\/CS20100588.","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"3312_CR87","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1513\/AnnalsATS.201408-399OC","volume":"12","author":"ET Smales","year":"2015","unstructured":"Smales ET, Edwards BA, Deyoung PN, et al. Trazodone effects on obstructive sleep apnea and non-REM arousal threshold. Ann Am Thorac Soc. 2015;12(5):758\u201364. https:\/\/doi.org\/10.1513\/AnnalsATS.201408-399OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"Suppl 1","key":"3312_CR88","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/dom.13129","volume":"20","author":"MA Nauck","year":"2018","unstructured":"Nauck MA, Meier JJ. Incretin hormones: their role in health and disease. Diabetes Obes Metab. 2018;20(Suppl 1):5\u201321. https:\/\/doi.org\/10.1111\/dom.13129.","journal-title":"Diabetes Obes Metab"},{"key":"3312_CR89","doi-asserted-by":"publisher","unstructured":"Shuster LT, Go VL, Rizza RA, O'Brien PC, Service FJ. Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes. Feb 1988;37(2):200-3https:\/\/doi.org\/10.2337\/diab.37.2.200.","DOI":"10.2337\/diab.37.2.200"},{"issue":"4","key":"3312_CR90","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3945\/jn.114.206029","volume":"145","author":"CC Ronveaux","year":"2015","unstructured":"Ronveaux CC, Tome D, Raybould HE. Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling. J Nutr. 2015;145(4):672\u201380. https:\/\/doi.org\/10.3945\/jn.114.206029.","journal-title":"J Nutr"},{"issue":"12","key":"3312_CR91","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1007\/s00125-015-3754-x","volume":"58","author":"JS ten Kulve","year":"2015","unstructured":"ten Kulve JS, Veltman DJ, van Bloemendaal L, et al. Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes. Diabetologia. 2015;58(12):2688\u201398. https:\/\/doi.org\/10.1007\/s00125-015-3754-x.","journal-title":"Diabetologia"},{"key":"3312_CR92","doi-asserted-by":"publisher","unstructured":"Zhang W, Waise TMZ, Toshinai K, et al. Functional interaction between Ghrelin and GLP-1 regulates feeding through the vagal afferent system. Sci Rep. 2020;10(1):18415. https:\/\/doi.org\/10.1038\/s41598-020-75621-5.","DOI":"10.1038\/s41598-020-75621-5"},{"issue":"2","key":"3312_CR93","first-page":"349","volume":"58","author":"E Bojanowska","year":"2007","unstructured":"Bojanowska E, Nowak A. Interactions between leptin and exendin-4, a glucagon-like peptide-1 agonist, in the regulation of food intake in the rat. J Physiol Pharmacol. 2007;58(2):349\u201360.","journal-title":"J Physiol Pharmacol"},{"key":"3312_CR94","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/606031","volume":"2015","author":"J Zhong","year":"2015","unstructured":"Zhong J, Gong Q, Goud A, Srinivasamaharaj S, Rajagopalan S. recent advances in dipeptidyl-peptidase-4 inhibition therapy: lessons from the bench and clinical trials. J Diabetes Res. 2015;2015: 606031. https:\/\/doi.org\/10.1155\/2015\/606031.","journal-title":"J Diabetes Res"},{"issue":"2","key":"3312_CR95","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jama.298.2.194","volume":"298","author":"RE Amori","year":"2007","unstructured":"Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA. 2007;298(2):194\u2013206. https:\/\/doi.org\/10.1001\/jama.298.2.194.","journal-title":"JAMA"},{"key":"3312_CR96","doi-asserted-by":"publisher","unstructured":"Zheng Z, Zong Y, Ma Y, et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):234. https:\/\/doi.org\/10.1038\/s41392-024-01931-z","DOI":"10.1038\/s41392-024-01931-z"},{"key":"3312_CR97","doi-asserted-by":"publisher","first-page":"204201882199732","DOI":"10.1177\/2042018821997320","volume":"12","author":"JM Trujillo","year":"2021","unstructured":"Trujillo JM, Nuffer W, Smith BA. GLP-1 receptor agonists: an updated review of head-to-head clinical studies. Ther Adv Endocrinol Metab. 2021;12:2042018821997320. https:\/\/doi.org\/10.1177\/2042018821997320.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"11","key":"3312_CR98","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989\u20131002. https:\/\/doi.org\/10.1056\/NEJMoa2032183.","journal-title":"N Engl J Med"},{"key":"3312_CR99","doi-asserted-by":"publisher","unstructured":"Brunton S. GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other? Int J Clin Pract. 2014;68(5):557\u2013567. https:\/\/doi.org\/10.1111\/ijcp.12361","DOI":"10.1111\/ijcp.12361"},{"key":"3312_CR100","doi-asserted-by":"publisher","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1411892.","DOI":"10.1056\/NEJMoa1411892"},{"issue":"6","key":"3312_CR101","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa2301972","volume":"389","author":"AM Jastreboff","year":"2023","unstructured":"Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-hormone-receptor agonist retatrutide for obesity\u2014a phase 2 trial. N Engl J Med. 2023;389(6):514\u201326. https:\/\/doi.org\/10.1056\/NEJMoa2301972.","journal-title":"N Engl J Med"},{"issue":"9","key":"3312_CR102","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1001\/jamainternmed.2024.2525","volume":"184","author":"PJ Rodriguez","year":"2024","unstructured":"Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, et al. Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity. JAMA Intern Med. 2024;184(9):1056\u201364. https:\/\/doi.org\/10.1001\/jamainternmed.2024.2525.","journal-title":"JAMA Intern Med"},{"issue":"22","key":"3312_CR103","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.jacc.2023.09.811","volume":"82","author":"J Butler","year":"2023","unstructured":"Butler J, Abildstrom SZ, Borlaug BA, et al. Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction. J Am Coll Cardiol. 2023;82(22):2087\u201396. https:\/\/doi.org\/10.1016\/j.jacc.2023.09.811.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"3312_CR104","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, Abildstrom SZ, Borlaug BA, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389(12):1069\u201384. https:\/\/doi.org\/10.1056\/NEJMoa2306963.","journal-title":"N Engl J Med"},{"issue":"24","key":"3312_CR105","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2307563.","journal-title":"N Engl J Med"},{"issue":"8","key":"3312_CR106","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1513\/AnnalsATS.201510-697OC","volume":"13","author":"T Matsumoto","year":"2016","unstructured":"Matsumoto T, Harada N, Azuma M, et al. Plasma incretin levels and dipeptidyl peptidase-4 activity in patients with obstructive sleep apnea. Ann Am Thorac Soc. 2016;13(8):1378\u201387. https:\/\/doi.org\/10.1513\/AnnalsATS.201510-697OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"3312_CR107","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jsr.12552","volume":"26","author":"S Reutrakul","year":"2017","unstructured":"Reutrakul S, Sumritsopak R, Saetung S, Chanprasertyothin S, Anothaisintawee T. The relationship between sleep and glucagon-like peptide 1 in patients with abnormal glucose tolerance. J Sleep Res. 2017;26(6):756\u201363. https:\/\/doi.org\/10.1111\/jsr.12552.","journal-title":"J Sleep Res"},{"key":"3312_CR108","doi-asserted-by":"publisher","unstructured":"Papamargaritis D, Al-Najim W, Lim JZM, et al. Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomized controlled trial. Lancet Reg Health Eur. 2024;39:100853. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100853.","DOI":"10.1016\/j.lanepe.2024.100853"},{"key":"3312_CR109","doi-asserted-by":"publisher","unstructured":"Gomez-Peralta F, Abreu C, Castro JC, et al. An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes. BMC Endocr Disord. 2015;15:78. https:\/\/doi.org\/10.1186\/s12902-015-0074-6.","DOI":"10.1186\/s12902-015-0074-6"},{"key":"3312_CR110","doi-asserted-by":"publisher","unstructured":"Blackman A, Foster GD, Zammit G, et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond). 2016;40(8):1310\u20139. https:\/\/doi.org\/10.1038\/ijo.2016.52.","DOI":"10.1038\/ijo.2016.52"},{"key":"3312_CR111","doi-asserted-by":"publisher","unstructured":"Dragonieri S, Portacci A, Quaranta VN, et al. Therapeutic potential of glucagon-like peptide-1 receptor agonists in obstructive sleep apnea syndrome management: a narrative review. Diseases. 2024;12(9). https:\/\/doi.org\/10.3390\/diseases12090224.","DOI":"10.3390\/diseases12090224"},{"issue":"1","key":"3312_CR112","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1365-2869.2012.01030.x","volume":"22","author":"I Idris","year":"2013","unstructured":"Idris I, Abdulla H, Tilbrook S, Dean R, Ali N. Exenatide improves excessive daytime sleepiness and wakefulness in obese patients with type 2 diabetes without obstructive sleep apnoea. J Sleep Res. 2013;22(1):70\u20135. https:\/\/doi.org\/10.1111\/j.1365-2869.2012.01030.x.","journal-title":"J Sleep Res"},{"issue":"13","key":"3312_CR113","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","volume":"391","author":"A Malhotra","year":"2024","unstructured":"Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391(13):1193\u2013205. https:\/\/doi.org\/10.1056\/NEJMoa2404881.","journal-title":"N Engl J Med"},{"key":"3312_CR114","doi-asserted-by":"publisher","unstructured":"Amezcua-Castillo E, Gonzalez-Pacheco H, Saenz-San Martin A, et al. C-reactive protein: the quintessential marker of systemic inflammation in coronary artery disease-advancing toward precision medicine. Biomedicines. 2023;11(9). https:\/\/doi.org\/10.3390\/biomedicines11092444.","DOI":"10.3390\/biomedicines11092444"},{"issue":"2","key":"3312_CR115","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1513\/AnnalsATS.202407-736OC","volume":"22","author":"CN Schmickl","year":"2025","unstructured":"Schmickl CN, Orr JE, Alex RM, et al. Combination drug therapy with acetazolamide, eszopiclone +\/- venlafaxine for obstructive sleep apnea (RESCUE-Combo): a randomized, double-blind, placebo-controlled clinical trial. Ann Am Thorac Soc. 2025;22(2):263\u201373. https:\/\/doi.org\/10.1513\/AnnalsATS.202407-736OC.","journal-title":"Ann Am Thorac Soc"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03312-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03312-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03312-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:33:19Z","timestamp":1757273599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03312-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":115,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3312"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03312-6","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bolong Xu has no conflicts of interest to declare. Kaveh Gaynor-Sodeifi has no conflicts of interest to declare. Vaishnavi Kundel has served on a one-time advisory panel for Apnimed, and is on the steering committee for a clinical trial by Eli Lilly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}